Skip to content

Screener

Eligibility screening

Testing Neratinib or Neratinib with Palbociclib for HER2+ Tumors

Sponsored by National Cancer Institute (NCI)Study detailsClinicalTrials.gov

184 US sites in AK, AL, CA, FL +27

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.